Accelerating the pace of engineered cell therapies, from lab to bedside
Kytopen is speeding up both discovery and delivery of engineered cell therapies with its transformative Flowfect platforms.
Biologists discover a trigger for cell extrusion
Study suggests this process for eliminating unneeded cells may also protect against cancer.
Cancer cells soften as they metastasize, study suggests
Developing drugs that prevent this softening might impede tumors’ ability to spread.
An artificial intelligence tool that can help detect melanoma
Using deep convolutional neural networks, researchers devise a system that quickly analyzes wide-field images of patients’ skin in order to more efficiently detect cancer.
Matthew Vander Heiden named director of the Koch Institute
MIT biology professor and pioneering researcher of cancer cell metabolism will succeed longtime director Tyler Jacks.
Big data dreams for tiny technologies
MIT research combines machine learning with nanoparticle design for personalized drug delivery.
Vaccination by inhalation
Delivering vaccines directly to the lungs can boost immune responses to respiratory infections or lung cancer, study finds.
Study: One enzyme dictates cells’ response to a probable carcinogen
Varying levels of a DNA repair enzyme can lead to very different outcomes after exposure to NDMA.
Membrane around tumors may be key to preventing metastasis
Tough as plastic wrap but elastic like a balloon, the lining could be a target for therapies to limit cancer cells from spreading.
Toward a disease-sniffing device that rivals a dog’s nose
Trained dogs can detect cancer and other diseases by smell. A miniaturized detector can analyze trace molecules to mimic the process.
Robert Weinberg receives 2021 Japan Prize
The award recognizes Weinberg’s pioneering achievements in the field of cancer biology.
3 Questions: Lindsay Case on how cells organize and sense the world
Case’s new lab investigates why cancer arises when disruptions in cellular organization change how cells sense mechanical forces.
Faster tracking of treatment responses
Biological sensors developed by MIT spinout Glympse Bio could help clinicians make decisions for individual patients.
Robust artificial intelligence tools to predict future cancer
Researchers created a risk-assessment algorithm that shows consistent performance across datasets from US, Europe, and Asia.
Catching cancer in the act
Using CRISPR technology, researchers are tracking the lineage of individual cancer cells as they proliferate and metastasize in real-time.